alnabhy medical: iv canula

الثلاثاء، 3 أغسطس 2010

iv canula

i v canula

ليست هناك تعليقات:

إرسال تعليق

اريد ارسل المواصفات والاسعار الى عنوانemail

( )

جيد_( ) - مقبول ( ) سيء( )

0.9% Sodium Chloride Intravenous Infusion Product Description

0.9% Sodium Chloride Intravenous Infusion Product Description Product Name: Sodium Chloride Injection Main ingredients and chemical name: Sodium Chloride Structural formula: NaCl Molecular formula: NaCl Molecular weight: 58.44 Character The product is a colorless clear liquid, with salt flavor. Pharmacology and toxicity Sodium chloride is an electrolysis supplement agent; Sodium and chloride are important electrolysis for the human body and mainly exist in extracellular fluid, which play an important role in maintaining normal volume of blood and extracellular fluid and osmosis pressure. Normal serum sodium concentration is about 135~145mmol/L, with a 92 percent of the plasma cation and a 90 percent of total osmosis pressure, so the quantity of plasma sodium play a decisive role for the osmosis pressure; Normal serum chloride concentration is about 98~106mmol/L; Sodium and chloride in human body are mainly adjusted by hypothalamus, lobus posterior hypophyseos and kindney so as to maintain the stability of body fluid volume and osmosis pressure. Pharmacokinetics Sodium chloride enter the blood circulation directly after injected by intravenous, and distribute widely in the human body, and mainly exist in extracellular fluid. Both sodium and chloride can be filtrated by glomerule, and partially be absorbed by renal tubules. Sodium chloride is mainly excreted through urine by kindney, some is excreted through sweat. Indications It is indicated for dehydration caused by all kinds of cases, including hypoosmolality, isotonia and hypertonicity; Also for the coma caused by hypertonicity non-ketosis diabetes as the administration of isotonia and hypoosmolality sodium chloride can correct the dehydration and hyperosmotic state; It is also indicated for low-chloride metabolic alkali poisoning; And external use sodium chloride can be used to wash the eyes and wounds; It also can be used for the induction of labor with wate4r bag. Side-effect (1)Overdose and over-rapidness of infusion may lead to retention of water and sodium, cause hydrops, increased blood pressure, increased heart rate, oppressed feeling in chest, breath hard, even left ventricular failure. (2)Overdose and over-rapidness of injection low-concentration sodium chloride may lead to haemolysis, cerebral edema and so on. Contraindication (1)diabetes ketosis acidose; (2)hyperglycemia non-ketosis hyperosmotic state; Attention (1)Avoid using the medicine for the following cases: Hydropsy, such as the kidney syndrome, liver cirrhosis, hydroperitoneum, congestive heart-failure, acute left ventricular failure, hydrocephalus, idiopathic edema and etc.; Acute kidney failure oliguria stage, chronic kidney failure decreased urine and bad reaction for diuretic; Hepertension; Hepo-potassium. (2)According to the clinical requirements, examine the concentration of sodium, potassium, chloride in the serum; Examine acid and alkali concentration equality index; Examine the renal function, blood pressure and cardio-pulmonary function. Pregnancy and Lactation Forbid to use the sodium chloride injection for the patients with hypertension of pregnancy syndrome. Pediatric Use The dosage and the speed should be controlled strictly. Geratology The dosage and the speed by drip should be controlled strictly. Interaction Pay attention to the incompatibility of drugs when Sodium Chloride Injection used as solvent or dilution. Overdose Overdose may lead to hypernatremia and hypo potassium, also may lead to the missing of bicarbonate. Specification: 500ml: 4.5g; 500ml: 2.25g Storage: Store in the closed container. Package: Plastic injection bottle

blood bage

blood bage 500 ml infusionBlow extruded Bag Rolled Bag One 250ml Blood Collection Bag with CPDA1 DB-01250 16G or 17G 50/100 36×36×18/51× 32×26 5/10 0.46 1$ One 350ml Blood Collection Bag with CPDA1 DB-01350 16G or 17G 50/100 36×36×18/51× 32×26 6/12 0.47 1$ One 450ml Blood Collection Bag with CPDA1 DB-01450 16G or 17G 50/100 36×36×18/51× 32×26 7/14 0.48 1.05$ One 500ml Blood Collection Bag with CPDA1 DB-01500 16G or 17G 50/100 36×36×18/51× 32×26 7.5/15 0.50 1.1$ One 250ml Bag with CPDA1 and one 100 to 200ml empty satellite bag DB-02250 16G or 17G 40 36 x 36 x 20 5.5 0.84 1.14 One 350ml Bag with CPDA1 and one 200 to 300ml empty satellite bag DB-02350 16G or 17G 40 36 x 36 x 20 6.8 0.85 1.15 One 450ml Bag with CPDA1 and one 300 to 400ml empty satellite bag DB-02450 16G or 17G 40 36 x 36 x 20 7.4 0.87 1.17 One 500ml Bag with CPDA1 and one 300 to 400ml empty satellite bag DB-02500 16G or 17G 40 36 x 36x 20 7.8 0.89 1.21 SETS/CARTO N Single Blood Bag CARTON SIZE(cm3) GROSS WEIGHT(kg) NAME SPECIFICATIO N DONOR NEEDLE GAUGE Unit Price(FOBShanghai) 5. Payment Term: By 100% T/T in advance-40% paid by T/T within 3 days when place the order and the balance to be paid by T/T before shipment. Or swift L/C at sight. 6. Package: Every set packed in a PE compounded vacuum bag, every three to five sets packed in an aluminum foil compounded bag. 7. Options of with anticoagulant or empty, the type of Anticoagulant, type of Blood Taking Needle, volume of blood bag etc. are available. 8.The sampling device, needle protector, platelet storage bag and in-line leukocyte filter are available. Double CPDA-1 Blood bag Address: A-1-1003, Tongcheng Plaza, No.538 Jianshe Ave., Wuhan, P. R. China430022 bage

dextrose5-10% 500 ml infusion bage

dextrose5-10% 500 ml infusion bageIntravenous Infusion Product Description Product Name: Dextrose Injection Main ingredients and chemical name: Dextrose Molecular formula: C6H12O6. H2O Molecular weight: 198.17 Character: The product is a colorless, or almost colorless clear liquid, with sweet flavor. Pharmacology and toxicity Dextrose is one of the heat origin for human body, 16.7kJ heat can be produced from one gram dextrose, so dextrose is usually be used for the supplement of heat and treatment of hypoglycaemia. When administered together with insulin by phleboclysis, because the synthesis of glucogen must be joined with potassium, thus the potassium enter into cell to make the concentration of potassium-plasma decreased, the dextrose injection can be used for the treatment of hyperpotassemia. Dextrose injection is administered fast intravenously can make tissue dehydrate, so the product can be used as dehydrating agent. Moreover, dextrose is main material which can maintain and adjust osmotic pressure of peritoneum dialysate. Pharmacokinetics Dextrose administered by phleboclysis usually enter the blood circulation directly. It is oxidized completely to produce CO2 and H2O and excreted by lung and kidney, accompanied with the production of heat. Available capacity of common people for dextrose is about 6mg/kg/minute. Indications 1) Used for supplement of energy and body liquid; Used for the scarcity of feeding and body liquid caused by all cases (such as vomiting, diarrhea ), intravenous hyperalimentation, ketosis; 2) hypoglycaemia; 3) hyperpotassemia; 4) 50% Dextrose could be used as dehydrant for body tissue.; 5) Used for the preparation of peritoneum dialyszte; 6) Used as medicine diluent; 7) Used for the test of dosis tolerate of dextrose administered by phleboclysis; 8) Used for the preparation of GIK. Contraindication 1) diabetes ketosis acidose; 2) hyperglycemia non-ketosis hyperosmotic state; Attention 1) High dose dextrose during parturition may stimulate the secretion of insulin for the fetus, which can lead to glycopenia. 2) The product should be administered cautiously in the following cases: : Tolerance test of oral dextrose for the patients whose stomach has been cut partially may lead to dumping syndrome and hypoglycemia. The patients with periodic paralysis or hypopotassemia; Stress condition or glucocorticoid administration may lead to hyperglycemia; When the product is administered for the patients with dropsy, cardiac and kidney insufficiency, and ascites due to cirrhosis, water retention may happen, so the administration dosage should be controlled; The drip speed should be controlled strictly for the patients with cardiac functional insufficiency. Pregnancy and Lactation High dose dextrose during parturition may stimulate the secretion of insulin for the fetus, which can lead to glycopenia. Pediatric Use Over-rapidness and overabundance may lead to cardio palmus, and cardiac arrhythmia, or even acute left ventricular failure Geratology Over-rapidness and overabundance may lead to cardio palmus, and cardiac arrhythmia, or even acute left ventricular failure Interaction Overdose Specification 500ml: 25g; 500ml: 50g StorageStore in the closed container. Packageplastic injection bottle Expiry datetwo years

alnabhy medical

الثلاثاء، 3 أغسطس 2010

iv canula

ليست هناك تعليقات:

إرسال تعليق

التسميات

المساهمون

قائمة المدونات الإلكترونية

قائمة المدونات الإلكترونية

sodium chloride 0.9 itravenous solution

dextrose500 ml intravenous solution

iv canula

insuline syringe

syringe

التسميات

dextrose 500 ml

التسميات

peauty

الثلاثاء، 3 أغسطس 2010

iv canula

ليست هناك تعليقات:

إرسال تعليق

قائمة المدونات الإلكترونية

قائمة المدونات الإلكترونية

اشتراك في مدونة النابهي التجاريه العلميه

sodium chloride 0.9 itravenous solution

dextrose500 ml intravenous solution

iv canula

insuline syringe

syringe

التسميات

dextrose 500 ml

التسميات

peauty